Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
about
Gender differences in genetic risk profiles for cardiovascular diseaseEight Americas: investigating mortality disparities across races, counties, and race-counties in the United StatesProspective study of one million deaths in India: rationale, design, and validation resultsGenome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17Bovine milk in human nutrition--a reviewIs bioelectrical impedance accurate for use in large epidemiological studies?Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseasesThe preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factorsModerate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanismsIschemic heart disease in women: a focus on risk factorsHeart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationLong-term effects of weight-reducing diets in people with hypertensionSystematic versus opportunistic risk assessment for the primary prevention of cardiovascular diseaseYoga for secondary prevention of coronary heart diseaseOrganisational interventions for improving control of blood pressure in individuals with hypertensionRisk scoring for the primary prevention of cardiovascular diseaseYoga for secondary prevention of coronary heart diseaseTranscendental meditation for the primary prevention of cardiovascular diseaseVasopressors and predominantly vasoconstrictive drugs for acute myocardial infarction complicated by cardiogenic shockExercise for people with high cardiovascular riskFixed-dose combination therapy for the prevention of cardiovascular diseaseHealth, not weight loss, focused programmes versus conventional weight loss programmes for cardiovascular risk factorsFixed-dose combination therapy for the prevention of cardiovascular diseaseSystematic versus opportunistic risk assessment for the primary prevention of cardiovascular diseaseTranscendental meditation for the primary prevention of cardiovascular diseaseInotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeYoga for secondary prevention of coronary heart diseaseInotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndromeLong-term effects of weight-reducing diets in hypertensive patientsIntra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shockExercise for people with high cardiovascular riskLong-term effects of weight-reducing diets in hypertensive patientsIntra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shockHypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritisGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsChromosome 9p21 variant predicts mortality after coronary artery bypass graft surgeryEffects of some common food constituents on cardiovascular diseaseRecent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.Drug discovery: lessons from evolutionA genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease
P2860
Q21092169-BB7E82A4-8936-4655-81E0-2E99C8F045CDQ21144705-F3CAB5FE-26D1-440F-9DA8-A20CBA74E6F3Q21144712-1265F29C-0E56-43DD-A7BA-1B642A4DD9DFQ21145265-794727A3-3B57-4C53-82D8-66153BFEEA57Q21245683-56AAC377-1377-4F00-BF35-6CAC945E54E2Q21245898-E4FDC3B7-55BD-455E-9CC2-457E2C43688AQ21285153-422E6289-B5BB-4063-8DBB-4ED7C0C7324DQ21563399-138398B4-43F4-4CCC-B427-97E1CBB9A077Q22251417-DCA9346A-7463-4545-A65E-6F35D9A3EE5AQ22251459-FFECCFE8-23F4-4552-B71C-FB00B86034B2Q22306356-4E78E926-6A3C-4185-835B-F7F1C895AD98Q24186055-A583661D-B18F-4AF7-9A7C-B6439BF61EC4Q24186332-22F19300-E8CC-46BF-B293-67D90EF7C4C9Q24186604-438BF069-4570-4659-8DB4-1ACDFB6658B9Q24186835-CF199B01-E886-47AE-B1B6-43A4D7F58053Q24186884-55DC3FB4-C9C3-4E5E-8B15-0161DA5BD300Q24187259-BDC0221D-ABD0-436C-8FC8-49A3B024B812Q24187502-1E22C0B5-1BF0-4BD6-92E9-92101DDB3BD3Q24187672-E574EAC9-2CAD-4ACB-85FF-F4AE7CCC921BQ24194404-F263F2B5-3F90-4248-B0F0-A1F2EC527473Q24195065-196EBE64-C88E-4D09-A6EB-B9AC324457DCQ24195100-47E16BF0-ACE4-44C6-9A4C-CD9B7C371EDCQ24198070-DFC88D23-0276-4BEC-AB7B-FB159DF40A32Q24201138-0A8EECF6-4FEC-4D1E-BF17-822E2CDB3F87Q24201203-EE69BC69-26C1-4EF3-B819-5C6D683021E5Q24201225-2A0B34B8-216A-41F9-BB83-10F822423C91Q24202534-F6F6E133-2140-4F43-86B5-C5D33DB619E7Q24203783-FD105C3D-7EDA-48E5-81D5-0FE498B567ACQ24234237-9E7A8177-5F3A-4398-9442-5808697CED17Q24235462-FF298522-BCD5-4814-8298-53F8FE00E027Q24236670-7B304E70-371D-48B2-A293-F6B3C065EA96Q24241677-E1DFD978-EE5C-4DE8-AD81-7A4281ACA062Q24242133-2232B535-A1BA-490D-8F02-980D4767A67FQ24242787-35B9A364-AC4C-4ABB-B9E6-EECE071ABC9DQ24550675-4C374E97-62B6-4617-91F8-1D9B2F3C0E09Q24602703-B8F6C332-D93D-4DF3-8101-61B888C952B4Q24605384-0F57E164-9041-4464-82CB-CFAC3AC41CD9Q24605881-2979A536-19CA-4097-AA89-9DBDD5EA98FDQ24610693-D712EE55-DCED-486F-8CEC-C0531A05C48EQ24615584-75424F2E-B87D-413D-BB17-516F329C4472
P2860
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Effect of potentially modifiab ...... ART study): case-control study
@ast
Effect of potentially modifiab ...... ART study): case-control study
@en
Effect of potentially modifiab ...... ART study): case-control study
@nl
type
label
Effect of potentially modifiab ...... ART study): case-control study
@ast
Effect of potentially modifiab ...... ART study): case-control study
@en
Effect of potentially modifiab ...... ART study): case-control study
@nl
prefLabel
Effect of potentially modifiab ...... ART study): case-control study
@ast
Effect of potentially modifiab ...... ART study): case-control study
@en
Effect of potentially modifiab ...... ART study): case-control study
@nl
P2093
P50
P3181
P1433
P1476
Effect of potentially modifiab ...... ART study): case-control study
@en
P2093
Alvaro Avezum
Fernando Lanas
INTERHEART Study Investigators
John Varigos
Liu Lisheng
Matthew McQueen
Stephanie Ounpuu
P304
P3181
P356
10.1016/S0140-6736(04)17018-9
P407
P577
2004-09-01T00:00:00Z